Morris Nichols Advises Checkpoint Therapeutics Special Committee on Acquisition

Morris Nichols, together with Cooley LLP, advised the special committee of the board of directors of oncology company Checkpoint Therapeutics Inc. in connection with a nearly $200 million acquisition by Sun Pharmaceutical Industries Ltd. Eric Klinger-Wilensky and Mac Measley led the team providing Delaware law counsel to the special committee.